We will be presenting at the Controlled Release Society 2020 Virtual Meeting!
Whilst we were looking forward to the opportunity to attend CRS 2020 in Las Vegas, the ongoing pandemic has meant that we have had to cancel our travel plans.
However, we are excited to support the Controlled Release Society take part in this innovative virtual CRS initiative.
We will be presenting the following research from our group. CRS 2020 registrants can access each by clicking the title below.
Pharmaceutical Formulation of Peptide Nanotubes for Drug Delivery Applications.
Presenter: Dr Garry Laverty
Co-authors: Simon Porter, Dr Sophie Coulter, Dr Sreekanth Pentlavalli.
Designated session for Q&A with Dr Garry Laverty : 9-10.30am (Irish/UK time) Thursday 2nd July 2020.
An Ultrashort Multifunctional Peptide Hydrogel as a Novel Matrix for Chronic Wound Healing
Presenter: Dr Sreekanth Pentlavalli
Co-authors: Dr Sophie Coulter and Dr Garry Laverty.
Poster number 63.
Peptide-like Hydrogels as Long-acting In Situ Forming Implants for Treatment and Prevention of HIV/AIDs.
Dr. Garry Laverty,* Dr. Sophie Coulter, Dr. Sreekanth Pentlavalli.
Designated session for Q&A with Dr Garry Laverty: 9-10.30am (Irish/UK time) Friday 3rd July 2020. Poster Meetup Session 3.
More info on the conference can be found by clicking here.
Hope to see you there! We will be there to answer questions on our work during the designated sessions outlined above.
Our peptide hydrogel research wins Controlled Release Society’s 2020 People’s Choice Award
We are excited to hear our research on the use of peptide hydrogels for HIV/AIDs drug delivery won the overall CRS People’s Choice Award at the recent CRS virtual meeting. The presentation, as well as our other work, is available to conference participants by clicking the relevant title below. Poster: Poster number 63. Peptide-like […]
Latest hydrogel work published in Chemical Communications
Our latest collaborative work on entitled “Tuning the antimicrobial activity of low molecular weight hydrogels using dopamine autoxidation,” has been accepted within Chemical Communications. This work was led by Emily Cross and represents a collaboration with Prof Dave Adams’ Group at the School of Chemistry University of Glasgow and is freely available here. Thanks again […]
Latest publication: Pharmaceutical formulation and characterization of dipeptide nanotubes for drug delivery applications
Our latest paper has been published in the journal Macromolecular Bioscience focusing on formulating peptide nanotubes using mild techniques to improve potential for pharmaceutical upscale. Paper can be accessed here: https://doi.org/10.1002/mabi.202000115 Abstract Peptide nanotubes are promising materials for a variety of biomedical applications with ultrashort (≤7 amino acids) forms providing particular promise for clinical translation. […]
Group receive major funding from EPSRC to develop peptide-like hydrogels for combined HIV-contraceptive therapy
We are excited to announce support from the Engineering and Physical Sciences Research Council (EPSRC) to develop of peptide-like hydrogels for use as a long-acting injectable delivery platform for combined HIV-contraceptive drug delivery. Total support (£766,542) will allow further development of our peptide-mimetic platforms in a key healthcare area in collaboration with our co-investigators at […]
Our book, Hydrogels: Design, synthesis & application in drug delivery & regenerative medicine, available now!
If you are interested in knowing more about the potential applications of our hydrogels, remember to check out our recent book “Hydrogels: Design, synthesis & application in drug delivery & regenerative medicine,” co-edited alongside Dr Raj Thakur and Prof Ryan Donnelly. Thanks to all those who contributed.
New website launch!!
Welcome to our new and improved website! We hope this provides an accessible means to which we can communicate our research to a wider audience. Please check back regularly for important updates from our group. We’d like to thank Artisan Web Design Belfast for their help in constructing the site and the Royal Society for providing […]
Our EPSRC research selected as case study
Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]
Research Group receive Innovate UK ICURe SETsquared Award
We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape. Our Research Associate Simon Porter is currently undertaking these […]